| Product Name | MF | CAS | Details |
|---|
| Angiotensinogen (1-14) (rat) | C89H123N21O21 | Details |
| Angiotensinogen (1-14), porcine | C85H123N21O20 | Details |
| Angiotensinogen(1-13), human | C79H116N22O17 | Details |
| Renin inhibitory peptide | C69H87N15O12 | Details |
| Ala-Pro-Gly-(Ile3,Val5)] Angiotensin II | C60H86N16O15 | Details |
| Asn1, Val5, Asn9] Angiotensin I, salmon | C59H87N17O14 | Details |
| Ile7]-Angiotensin III | C43H68N12O9 | Details |
| Val4]-Angiotensin III | C45H64N12O9 | Details |
| C45H66N14O10 | Details |
| Acetyl-AngiotensinI | C64H91N17O15 | Details |
| Angiogenin (108-122) | C78H125N25O23 | Details |
| Angiogenin (108-123) | C83H132N26O24 | Details |
| Angiotensin I/II (1-5) | C30H48N8O9 | Details |
| Angiotensin I/II (1-6) | C36H55N11O10 | Details |
| Angiotensin I/II (3-7) | C31H45N7O7 | Details |
| Angiotensin I/II (3-8) | C40H54N8O8 | Details |
| Angiotensin II (4-8), human | C35H45N7O7 | Details |
| Angiotensin II Antipeptide | C42H62N10O12 | Details |
| Angiotensin II, flounder | Details |
| Angiotensin III Antipeptide | C37H55N9O9 | Details |
| Angiotensin(1-12)(human) | C73H109N19O16 | Details |
| Angiotensin(1-12)(mouse, rat) | C77H109N19O17 | Details |
| PFHLLVYS | Details |
| Details |
| C26H36N6O5 | Details |
| C46H66N12O9 | Details |
| C49H70N14O11 | Details |
| (Des-Arg10,Leu9)-Kallidin | C47H75N13O11 | Details |
| (Des-Arg9,Leu8)-Bradykinin | C41H63N11O10 | Details |
| (Tyr8)-Bradykinin | C50H73N15O12 | Details |
| Ile-Ser]-Bradykinin | C59H89N17O14 | Details |
| Met-Lys0] Bradykinin | C61H94N18O13S | Details |
| Tyr0]Bradykinin | C59H82N16O13 | Details |
| Bradykinin(2-7) | C29H40N6O8 | Details |
| Kallidin | C56H85N17O12 | Details |
| Ala107]-MBP(104-118) | C67H104N20O19 | Details |
| Tyr19] Diazepam-Binding Inhibitor Fragment | C90H147N25O31 | Details |
| Ala113]-MBP(104-118) | C67H104N20O19 | Details |
| Ala9] Autocamtide 2 | C64H116N22O19 | Details |
| Des-Asp1]-Angiotensin I, Human | C58H84N16O11 | Details |
| Lys3, Phe10, Tyr13]-Autocamtide-2-Related Inhibitory Peptide (AIP) Analog | C74H121N23O20 | Details |
| pThr3]-CDK5 Substrate | C53H100N15O15P | Details |
| Ser25]-PKC (19-36) Substrate | C93H159N35O25 | Details |
| Handle region peptide, rat | C54H101N15O12S | Details |
| Leptin (116-130) (human) | Details |
| Peptide5 | C60H98N16O20S | Details |
| β-Interleukin I (163-171), human | C39H64N12O19 | Details |
| C45H68N12O12 | Details |
| PAR-1 (1-6) (mouse, rat) | C37H54N10O9 | Details |
| PAR-2 (1-6) amide (human) (scrambled) | C28H54N8O7 | Details |
| PAR-2 (6-1) amide (human) | C28H54N8O7 | Details |
| PAR-2 (6-1) amide (mouse, rat) | C29H56N10O7 | Details |
| PAR-3 (1-6) (human) | C29H45N9O8 | Details |
| PAR-4 (1-6) (human) | C28H41N7O9 | Details |
| TRAP-5 amide | C30H51N9O6 | Details |
| VHLTP | Details |
| Ac2-12 | C63H94N14O17S | Details |
| CRP (201-206) | C38H57N9O8 | Details |
| CRP (77-82) | C23H40N6O10 | Details |
| Details |
| Lys1015, 1024]-Thrombospondin-1(1015-1024), human | Details |
| Thrombospondin-1 (1016-1021) (human, bovine, mouse) | C39H59N9O8S | Details |
| Thrombospondin-1 (1016-1023) | C56H81N13O10S | Details |
| (Phe1,Ser2)-TRAP-6 | C34H56N10O9 | Details |
| GHRP | C45H55N9O6 | Details |
| GHRP amide | C19H32N10O4 | Details |
| GPRP amide | Details |
| Hirudin(54-65)(desulfated); | C66H93N13O25 | Details |
| Tyr4]-MBP(1-11) | C55H85N21O18 | Details |
| Ac-MBP(1-11) | C53H95N21O18 | Details |
| Ac-RYYRIK-amide | C44H70N14O9 | Details |
| AKT/PKB/RProtein Kinase Substrate [ARKRERTY-pS-FGHHA], Phosphorylated | Details |
| AKT/PKB/RProtein Kinase Substrate [ARKRERTYSFGHHA], Biotinylated | Details |
| Angiotensin II Substrate | C50H72N13O15P | Details |
| Angiotensinogen(1-14), human | C83H122N24O19 | Details |
| Anxiety Peptide | C81H138N24O29 | Details |
| APYA | C13H13N3O3S | Details |
| Biotin-MBP, MAPK Substrate | Details |
| Biotin-MBP, MAPK Substrate, Phosphorylated | Details |
| BPP 5a | C30H41N7O7 | Details |
| Calmodulin Dependent Protein Kinase Substrate Analog | Details |
| cAMP Dependent PK Inhibitor (5-24), amide | C94H149N33O30 | Details |
| cAMP Dependent PK Inhibitor, PKI (14-24), amide | C49H86N24O15 | Details |
| Cdc25A (80-93) (human) | C60H90N14O24S | Details |
| CDK5 Substrate | C53H99N15O12 | Details |
| CDK5 Substrate [PKTPKKAKKL], Biotinylated | C63H113N17O14S | Details |
| CFTR(108-117), Pseudomonasaeruginosa Inhibitor | Details |
| CGMP Dependent Kinase Inhibitor Peptide | C38H74N18O10 | Details |
| CTCE9908 peptide | Details |
| delta PKC (8-17) | Details |
| DNA-PK Substrate | C82H123N19O24 | Details |
| EGF Receptor Substrate 2 [DADE-pY-LIPQQG | C54H82N13O24P | Details |
| EGF Receptor Substrate 2 [DADE-pY-LIPQQG], Biotinylated | C64H96N15O26PS | Details |
| EGFR Protein Tyrosine Kinase Substrate [ADEYLIPQQ], Biotinylated | C58H87N13O19S | Details |
| epsilon PKC (82-92), C2 Domain | Details |
| Epsilon-V1-2 | C37H65N9O13 | Details |
| epsilon-V1-2, epsilon-PKC Inhibitor, Cys-conjugated | Details |
| Fibrinogen Binding Inhibitor Peptide | C50H80N18O16 | Details |
| HSDVHK-NH2 | C30H48N12O9 | Details |
| Human PD-L1 inhibitor II | Details |
| Product Total： Product Page： | ||||
| 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 | ||||